Ireland Kidney Function Test Market By Type (Urine Tests and Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2028F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIreland Kidney Function Test Market By Type (Urine Tests and Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2028F
The Ireland Kidney Function Test Market is expected to grow at an impressive rate during the forecast period due to the rising kidney or renal dysfunction, increasing investments by market players, rising R&D activities, high prevalence of kidney diseases, rising government initiatives, and technological innovations. These factors are expected to significantly drive the growth of the Ireland Kidney Function Test market.
Additionally, the rise in healthcare initiatives and schemes is expected to bolster the growth of the Ireland Kidney Function Test Market in the forecast period 2024-2028. For instance, Nova Biomedical launched a novel tool with advanced technology in March 2022 to promote kidney treatment by early diagnosis of the illness and renal function testing in 'Point-of-care testing (POCT)' settings outside of the hospital. The company's technology has been validated in clinical studies conducted in a variety of non-hospital settings, including community health centers, pharmacies, imaging facilities, doctor's offices, clinics, and individual home testing.
A kidney function test refers to a series of medical tests and diagnostic procedures such as the Blood Urea Nitrogen (BUN) Test, Serum Creatinine Test, Glomerular Filtration Rate (GFR) Calculation, and Kidney Biopsy, etc. These tests are performed to assess the health and functionality of the kidneys and provide valuable information about their ability to filter waste products, regulate fluid and electrolyte balance, and produce hormones necessary for maintaining overall health.
The growing prevalence of acute kidney injury (AKI) and associated chronic kidney disease (CKD) is projected to drive the kidney function tests market during the forecast years. Chronic kidney diseases refer to persistent renal function and structural deformities that have been present for a minimum of 3 months. Lifestyle diseases and kidney injuries are significant risk factors for kidney diseases and are the foremost cause of illness and death across Ireland. According to an article published in 'Our health service' journal, Chronic Kidney Disease (CKD) affects 1 in 10 people. Often described as 'a silent illness hiding in plain sight', it usually develops slowly over time and can progress to total kidney failure. It is estimated that CKD will become the fifth leading cause of death globally by 2040. Over 500 new patients in Ireland develop kidney failure every year. Early diagnosis of chronic kidney disease (CKD) through screening is key to better health outcomes while easing the burden on our health service. The Irish Kidney Association (IKA), in association with the HSE's National Renal Office (NRO), is running an awareness campaign to highlight the importance of early screening for chronic kidney disease (CKD). This, in turn, is expected to propel the growth of the Ireland Kidney Function Test market.
Furthermore, the increased adoption of digital urinalysis indicates the growing demand for home diagnostics, which is driving the growth of the Ireland Kidney Function Test Market. Several companies are developing FDA-cleared at-home smartphone urinalysis tests to help people seeking kidney tests for proteins. The company's urinalysis test uses disposable cups and strips in combination with a smartphone camera to interpret and read results prominently.
Rising Prevalence of Chronic Kidney Diseases
The increasing prevalence of kidney diseases, such as chronic kidney disease (CKD), diabetic nephropathy, and renal infections, is a major driving force behind the kidney function test market. As the incidence of these conditions rises, the demand for diagnostic tests to assess kidney function and detect diseases early also increases, thus boosting the growth of the Ireland Kidney Function Test Market. According to a research paper published in an article, the prevalence of CKD in the health system was 11.8%, 10.9% in men, and 12.6% in women. This corresponds to a detection rate of 4.5% (5.1% in women and 3.9% in men). The prevalence of CKD was significantly higher in women than in men (12.6% versus 10.9%, P < 0.001), older age groups, and patients with a history of Acute Kidney Injury (AKI). Therefore, the prevalence of CKD in the Irish health system is 11.8%, corresponding to a detection rate of 4.5% in the general population. Demographic and geographic factors, as well as acute kidney injury episodes, are important determinants of chronic kidney disease compared to other diseases. Thus, this factor is expected to bolster the growth of the Ireland Kidney Function Test Market.
Increasing Prevalence of Diabetes and Hypertension
According to National Institute of Health, the prevalence of the four main categories of chronic diseases among adults in Ireland has been estimated to be 9.4% for asthma, 9.8% for Chronic obstructive pulmonary disease (COPD), 5.2% for diabetes, and 4.3% for Cardiovascular (CVD).
Government Initiatives and Schemes
The Irish government has implemented various healthcare initiatives and policies to address the growing burden of chronic diseases, including kidney-related conditions. These initiatives aim to enhance early detection, improve patient outcomes, and reduce healthcare costs. As a result, kidney function tests receive support and attention, contributing to the growth of Ireland Kidney Function Test Market. Chronic Kidney Disease (CKD) significantly increases the risk of negative outcomes in people living with diabetes, cardiovascular disease and high blood pressure amongst other health conditions. Therefore, the IKA’s campaign aims to highlight that it is possible to prevent or slow down the progression of kidney disease through lifestyle changes and medication and that it all starts with simple blood and urine tests done by GP to measure and monitor kidney health. As per the tagging line provided by the Irish Government, the Irish Kidney Association’s campaign is ‘We’re Counting on You’. This represents the importance for the public to be proactive in managing their kidney health and that they are being ‘counted on’ to get a simple blood test and urine test which will reveal their kidney function ‘numbers’. These ‘numbers’ will represent how well the kidneys are functioning in filtering blood and removing waste from the body. If Chronic Kidney Disease (CKD) is detected early enough, its progression, through the five stages of CKD, can be slowed down supporting better patient outcomes.
Personalized Medicine and Precision Diagnostics
The trend toward personalized medicine, where treatment approaches are tailored to individual patients, also impacts the kidney function test market. Advancements in genetic testing, molecular diagnostics, and biomarker identification enable better risk assessment, early detection, and targeted treatment strategies. The integration of precision diagnostics in kidney function testing enhances its value and relevance in personalized patient care. Personalized medicine and precision diagnostics facilitate the early detection of kidney diseases or disorders. By utilizing genomic testing, proteomic analysis, and other advanced diagnostic tools, healthcare professionals can identify individuals who are at a higher risk of developing kidney problems. Early detection enables timely interventions and preventive measures to slow down the progression of kidney diseases, potentially reducing the burden on the healthcare system and leading to the growth of the Ireland Kidney Function Test Market.
Market Segmentation
The Ireland Kidney Function Test Market is segmented by type, component, end user, regional landscape, and competitive landscape. Based on type, the market is further bifurcated into urine tests and blood tests. For urine tests, the market is segmented into Urine Protein Tests, Creatinine Clearance Tests, and Microalbumin Tests. Based on blood tests, the market is bifurcated into Serum Creatinine Tests, Glomerular Filtration Rate Tests, and Blood Urea Nitrogen Tests. Based on the component, the market is segmented into Dipsticks, Reagents, Kits & Assays, and Others. Based on the end user, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, and Others.
Market Players
Baxter Healthcare Limited, Abbott Ireland Limited, Sysmex Ireland, Hoffmann-La Roche Ireland Limited, Danahar Corporation Ireland Limited, Nova Biomedical Ireland Limited, Siemens Healthineers Ireland, Arkray Ireland Limited, Fresenius Kabi Ireland, Randox Laboratories Ltd etc. are some of the leading companies operating in the Ireland Kidney Function Test Market.
| Attribute | Details |
| Base Year | 2022 |
| Historical Years | 2018 – 2021 |
| Estimated Year | 2023E |
| Forecast Period | 2024F – 2028F |
| Quantitative Units | Revenue in USD Million, CAGR for 2018-2022 and 2023E-2028F |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Type Component End User Region Company |
| Region Scope | Northern Ireland, North-West, West, Midland East, Dublin, Shannon, South-East, Cork-Kerry |
| Key Companies Profiled | Baxter Healthcare Limited, Abbott Ireland Limited, Sysmex Ireland, Hoffmann-La Roche Ireland Limited, Danahar Corporation Ireland Limited, Nova Biomedical Ireland Limited, Siemens Healthineers Ireland, Arkray Ireland Limited, Fresenius Kabi Ireland, Randox Laboratories Ltd |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Report Scope
In this report, Ireland Kidney Function Test Market has been segmented into following categories, in addition to the industry trends which have also been detailed below
- Ireland Kidney Function Test Market, By Type
- Ireland Kidney Function Test Market, By Urine Tests
o
- Ireland Kidney Function Test Market, By Blood Tests
o
- Ireland Kidney Function Test Market, By Component
- Dipsticks
- Reagents
- Kits & Assays
- Others
- Ireland Kidney Function Test Market, By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Ireland Kidney Function Test Market, By Region
- Northern Ireland
- North-West
- West
- Midland East
- Dublin
- Shannon
- South-East
- Cork-Kerry
Competitive Landscape
Company Profiles
found at Customizations
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are found at for the report
Company Information
Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy